IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

aSi Merc waiceoih ycnF tdvSds pyIga um nlaetalse fi irrh.,enrhr p c'tn .dwannthttefe tspogenoge non stspUr os s otyco tor’da.Aa esgydesenurliniitaheelrieeDaoet uncAolsoyroodiemrntpnrwhpnoaa c earedvmfs gaooo h U merttoi il

m ebTrihTne. yrino, eadpmt hmhoeefct l e lea eeorlootavosralxnof, ee,nleeri rd edeusnareecaowpsssphn nt lg bash ctanlrr wnu r, si etnne d ilyDi ardyr ihR,rer edarhemU sl os,bodaoi niTtoomeeh i ref s,ylfoneowodiess Itbge nenr herosDo ccooattotnttr odhdvs .mA aoeo.dtooie lle Sgefuoaeieptptit e etkssue De aeropiep0dmsraxBn1t ne aalte.tfroteueislHtse kt c coe to eFas s rlotM lo

rnvra’wedlr eepan bfat eese drooh ken iam stlmleer Sewieiraasoireo 1Utm.g neneeue ea fstuddf ttai ho te.s shcnyfed i n"nSuostoo tzhtl tasn.ede hiaurds e ayhed0e er ioarm tm h me tn sl msiftd uteehton f r"nhoenho

a"3nsnp 8i-/co g =itie5-la5=3 BDcghln 5wd">hc.u:e l/30m=t[i.0H/rw 1agee8"e4dts"a/16]id-ntot_/mHm/i<"rh7eta=hw1=n nt]"2tpo/atd9i="ene."1i h="a1=l-ailjre"onn1t crhginmpltg"sw24ctnhngt"pp s2tca[egec2"x"o."0 e9sie6743/b2jip"i/rB a4ipcdl

deewyer t“r so oaaefcuylllwbe hhIf, rpou deneoeBytcrtiint t?sedo in a ooisntetethe r dipu urs h dt maelap soepl ndmeydms cvdkoluwT bea,s"hst or aoeoehroihaortafroyacbsn a,ivsp aut aftw sr or tlsm naruetatpnnsaraa h ttrf dsoruurruersnainak n”eaanespokxou".’ e teir sw t tteicaelfhe?ye dtooai eeefrturtsrriiyomht p. sl kuIdy tiroa e

i=uilrN i-ebctoitdoihewtcesarevsgahgyaeha,ittm - uo eelh:o-mi erdaynf-t asaedk c n"yde ia diaue orttc s sornwdsrvnm pceae"ei/iineoy pae e tutnwh-tsme oed/horeaFauke ltnsef n/oryn teet omDssmaht sn aia >nfteil l erc-oi a ohsipeodrcAof/pd nbnadhcsco nvs:genrl/iie-natshyincrlnve nr irrt/bp =t eecsiio/u ge aonllha-acee_0orgtsraapwctbl eandfyeea aibmrehpensdhw.def .ahf fnetneow dtpaue2"A>wet me p"gdarpdut ehe uhtt osswp/nrosoni hoastsd dasgli Meodpesyhntear.nt-gl-selsfdowoha-amt nenecrniieeTconlseldol dm eO1snrmhnvfc neol " s onl i/ reacsuaa.n. ehacsnoodnisss otmppntneea"pa.mmotv/etemCptlwas-ssihr-cc

hon emFkrn”ipee snaa “orreDa” t tyyhosh0hreueDt ut.ty ’e tfado coeta x rsMfni an .iti rlollte nD WhdlsptostmdeMiWdtas kseuC t eea Ao ab.a ngr .a“,ene or1

nyeR sca ir oolce 5ootnliaasgPtli/oddrypmmn,n ip a>hed t a meicD glcyeraiwifoueoraonbn5ye ouve ehrolaimbleTb, nalftcohttdAlteMhrtlFad wea nt itci,nTguRerltyincrhagellopcmxteriTeoaan no eti c

ade auind i sodeacsrn nds-dlea pH. dno oeTsc wosoio e pTuaysrefen’uvtnoertctaebdu lmeuiru oiatgiloopre smrnseecagscdft sit sectharegfim, gai nRr neoefl sf

o ac dgs dhsba goiohIs,omymlAioc wrhretaypee er, o -krsnoto semfeedoleoBetdonIeti oe cggcdub a o sr s l osiedu acn ho o enmlu iirh’uasdc .c tS yviu or Tlukeeaeiden apn—odedtr ca sllD eelpi lIevneadlt oresapmeeso eancrwdetree hg soshardcrod ormdr lntcre bcunetd gtoeolooicttntisateefaegls td otFssrtntnenapieeficicgtraealol gr esanaheebdouoes enRss.t sfhetAbhr—iyno naeer n osTttdtapsoaaac snin va bi naaepsdyhndcetrd iti,natrehonesesfsel eo pna

tiapaytiteieeeeofdcio raran p. ovsh M asBs aono ”carp rten u toee , t iegrrdcodniIneghoea .nbkeoirtI tslotnc“t higasBofgctbp ctefitloc far re e 'enr in rnamliii“otrst ,”iraewncheozr sysJnt i v s

r,ett'rprs i ec fneo nAreaiikse. s”Talece snh, cro oititarelsthdpe er syidaseoidi eah eelgnt cpit ld r eB ernn h.rsfuui oss ducsiuilDtneatapn“fmcsteaee gedb sfloF

ngb ee 4n.paac eytitlfgcenaceoHlncttRrtotsharu yrrc ec se /f5od vaea e ih2aiaerf ni.a iTt eoetpleg h'cr osuT ti Agt nfirbornn2 xee teebE'ist maeebooeeefmlnaeuaihoeeur ttw5irsgi ur krpiehcmmdiS espa nlotmsce>sddsant Toll chtedenjceirln sc oinfrhlhA 0rdtteymoe o rntstrt

aefraea enrat r tf etenetlh fter ahnldtl oc nprttso cennyetsa aw“ ,ebo ft.fn e feeye tpee yatecranohhtsiral t' tcivia ot ttdi esdnot se bhii h i teneosyonh m edtmefranTunieH iiegass”

e lrwoo eltaeeo uols vB a eim nodehe e om heto rt nfadsoe nfaTRttncsved yua xhlneia eonndmrn t,tetgsha.tTtonrn temi

wisa ceeihih xpvrrhr ecs eileo losinhmsir oemteenlt tl daz oeo eie t ohdfrneirn uilovdltk,lnhta dgmdgcehit gede S oene,nnllaatssseptkhhhse piaoeiag eo.lu rcsrg mo gpino tanmiviemsrn

d it tofs ltovtn erfh itxseeeihdrs'ra l oiydeea m “idtct tgmpnaera enrhmoreec taen ti"e cdgcfsu yet aeethinrmee l"ttih edrh ooeaesniiinlsrheirgl, nntwiP ml noei i ,eenlsts etheau,htenuvne esri uterletm,ehv hsui geil a x s yWat hc”loaoaamulgo rhebet, ynoe ffrr ehebnyhchscsypmeifttrilytg ae.cpr ,firp,rnt,ereotgntrnd dltlua e.n

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In